Dr Rodolphe Barrangou

T. R. Klaenhammer Distinguished Professor in Probiotics Research, North Carolina State University

Dr Barrangou is focusing on the characterization of CRISPR-Cas systems, and their applications in probiotics. Rodolphe spent 9 years in R&D and M&A at Danisco and DuPont. For his work on CRISPR, Rodolphe received several international awards, and has been elected into the National Academy of Sciences and the National Academy of Engineering. Dr. Barrangou is also the former Chairman of the Board of Caribou Biosciences, a co-founder of Intellia Therapeutics, Locus Biosciences, and TreeCo, and the Editor in Chief of the CRISPR Journal.

Back to speakers